Sporotrichoid cutaneous infection by Mycobacterium haemophilum in an aids patient;Infección cutánea esporotricoide por Mycobacterium haemophilum en un paciente con sida

Actas Dermo-Sifiliograficas

Volumn 98, Issue 3, 2007, Pages 188-193

  Cameselle Martínez, Daniel ^a   Hernandez J ^a   Frances A ^a   Montenegro, T ^a   Canas F ^a   Borrego, L ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

AIDS; HIV; Immunosuppression; Mycobacterium haemophilum; Sporotrichoid

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; EFAVIRENZ; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; RIFAMPICIN; TENOFOVIR;

ACID FAST BACTERIUM; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIUM IDENTIFICATION; BITE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; FISH; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYBRIDIZATION; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM HAEMOPHILUM; SKIN DEFECT; SKIN INFECTION; SKIN INFLAMMATION; SKIN NODULE; SKIN ULCER; SPOROTRICHOID SKIN INFECTION; TREATMENT OUTCOME;

EID: 34250621962     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(07)70044-3     Document Type: Article

References (41)

1. Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev. 1996;9:435-47.
2. Shah MK, Sebti A, Kiehn TE, Massarella SA, Sepkowitz KA. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis. 2001;33:330-7.
3. Sompolinsky D, Lagziel A, Naveh D, Yankilevitz T. Mycobacterium haemophilum sp. nov., a new pathogen of humans. Int J Syst Bacteriol. 1978;28:67-75.
4. Sompolinsky D, Lagziel A, Rosenberg I. Further studies of a new pathogenic mycobacterium (M. haemophilum sp. nov.). Can J Microbiol. 1979;25:217-26.
5. Valdés F, Cid A. Micobacterias atípicas (revisión). Actas Dermosifiliogr. 2004;95:331-57.
6. Rogers PL, Walker RE, Lane HC, Witebsky FG, Kovacs JA, Parrillo JE, et al. Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome. Am J Med. 1988;84:640-2.
7. Smith S, Taylor GD, Fanning EA. Chronic cutaneous Mycobacterium haemophilum infection acquired from coral injury. Clin Infect Dis 2003;37:e100-1.
8. Geisler WM, Harrington RD, Wallis CK, Harnisch JP, Liles WC. Broad spectrum of dermatologic manifestations caused by Mycobacterium haemophilum infection. Arch Dermatol. 2002;138:229-30.
9. Friedli A, Krischer J, Hirschel B, Saurat JH, Pechere M. An annular plaque due to Mycobacterium haemophilum in a patient with AIDS. J Am Acad Dermatol. 2000;43:913-5.
10. Lefkowitz RA, Singson RD. Considering Mycobacterium haemophilum in the differential diagnosis for lytic bone lesions in AIDS patients who present with ulcerating skin lesions. Skeletal Radiol. 1998;27:334-6.
11. Bartralot R, Pujol RM, García-Patos V, Sitjas D, Martín-Casabona N, Coll P, et al. Cutaneous infections due to non-tuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol. 2000;27:124-9.
12. Von Stebut E, Wiest K, Braeuninger W. Chronic infiltrates and persisting ulcerations on the arms and legs. Arch Dermatol. 2005;141:897-902.
13. McBride ME, Rudolph AH, Tschen JA, Cernoch P, Davis J, Brown BA, et al. Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections. Arch Dermatol. 1991;127:276-7.
14. Vadney FS, Hawkins JE. Evaluation of a simple method for growing Mycobacterium haemophilum. J Clin Microbiol. 1985;22:884-5.
15. Bruijnesteijn van Coppenraet LE, Kuijper EJ, Lindeboom JA, Prins JM, Claas EC. Mycobacterium haemophilum and lymphadenitis in children. Emerg Infect Dis 2005;11:62-8.
16. Martín-Casabona N, Rosselló-Urgell J. Micobacterias ambientales en España: aislamientos en el periodo 1976-1996. Med Clin (Barc). 2000;115:663-70.
17. Tortoli E, Nanetti A, Piersimoni C, Cichero P, Farina C, Mucignat G, et al. Performance assessment of new multiplex probe assay for identification of mycobacteria. J Clin Microbiol. 2001;39:1079-84.
18. Dawson DJ, Jennis F. Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum. J Clin Microbiol. 1980;11:190-2.
19. Davis BR, Brumbach J, Sanders WJ, Wolinsky E. Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med. 1982;97:723-4.
20. Ryan CG, Dwyer BW. New characteristics of Mycobacterium haemophilum. J Clin Microbiol. 1983;18:976-7.
21. Branger B, Gouby A, Oules R, Balducchi JP, Mourard G, Fourcade J, et al. Mycobacterium haemophilum and Mycobacterium xenopi associated infection in a renal transplant patient. Clin Nephrol. 1985;23:46-9.
22. Kiehn TE, White M, Pursell KJ, Boone N, Tsivitis M, Brown AE, et al. A cluster of four cases of Mycobacterium haemophilum infection. Eur J Clin Microbiol Infect Dis. 1993;12:114-8.
23. White MH, Papadopoulos E, Small TN, Kiehn TE, Armstrong D. Mycobacterium haemophilum infections in bone marrow transplant recipients. Transplantation. 1995;60:957-60.
24. Cooper DK, Lanza RP, Oliver S, Forder AA, Rose AG, Uys CJ, et al. Infectious complications after heart transplantation. Thorax. 1983;38:822-8.
25. Lederman C, Spitz JL, Scully B, Schulman LL, Della-Latta P, Weitzman I, et al. Mycobacterium haemophilum cellulitis in a heart transplant recipient. J Am Acad Dermatol. 1994;30:804-5.
26. Fairhurst RM, Kubak BM, Pegues DA, Moriguchi JD, Han KF, Haley JC, et al. Mycobacterium haemophilum infections in heart transplant recipients: case report and review of the literature. Am J Transplant. 2002;2:476-9.
27. Artenstein AW, Fritzinger D, Gasser RA Jr, Skillman LP, McEvoy PL, Hadfield TL. Infection due to Mycobacterium haemophilum identified by whole cell lipid analysis and nucleic acid sequencing. Clin Infect Dis. 1994;19:1155-7.
28. Darling TN, Sidhu-Malik N, Corey GR, Allen NB, Kamino H, Murray JC. Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin. Br J Dermatol. 1994;131:376-9.
29. Males BM, West TE, Bartholomew WR. Mycobacterium haemophilum infection in a patient with acquired immune deficiency syndrome. J Clin Microbiol. 1987;25:186-90.
30. Dever LL, Martin JW, Seaworth B, Jorgensen JH. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin Infect Dis. 1992;14:1195-200.
31. Straus WL, Ostroff SM, Jernigan DB, Kiehn TE, Sordillo EM, Armstrong D, et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med. 1994;120:118-25.
32. Dawson DJ, Blacklock ZM, Kane DW. Mycobacterium haemophilum causing lymphadenitis in an otherwise healthy child. Med J Aust. 1981;2:289-90.
33. Thibert L, Lebel F, Martineau B. Two cases of Mycobacterium haemophilum infection in Canada. J Clin Microbiol. 1990;28:621-3.
34. Armstrong KL, James RW, Dawson DJ, Francis PW, Masters B. Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. J Pediatr. 1992;121:202-5.
35. Centers for Disease Control (CDC). Mycobacterium haemophilum infections-New York City metropolitan area, 1990-1991. MMWR Morb Mortal Wkly Rep. 1991;40:636-7.
36. Bernard EM, Edwards FF, Kiehn TE, Brown ST, Armstrong D. Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Antimicrob Agents Chemother. 1993;37:2323-6.
37. Soubani AO, al-Marri M, Forlenza S. Successful treatment of disseminated Mycobacterium haemophilum infection in a patient with AIDS. Clin Infect Dis. 1994;18:475-6.
38. Paech V, Lorenzen T, von Krosigk A, von Stemm A, Meigel WM, Stoehr A, et al. Remission of cutaneous Mycobacterium haemophilum infection as a result of antiretroviral therapy in a human immunodeficiency virus-infected patient. Clin Infect Dis. 2002;34:1017-9.
39. Hanau LH, Leaf A, Soeiro R, Weiss LM, Pollack SS. Mycobacterium marinum infection in a patient with the acquired immunodeficiency syndrome. Cutis. 1994;54:103-5.
40. Murdoch ME, Leigh IM. Sporotrichoid spread of cutaneous Mycobacterium chelonei infection. Clin Exp Dermatol. 1989;14:309-12.
41. Dore N, Collins JP, Mankiewicz E. A sporotrichoid-like Mycobacterium kansasii infection of the skin treated with minocycline hydrochloride. Br J Dermatol. 1979;101:75-9.